Roivant Sciences (ROIV) Total Liabilities (2021 - 2026)

Roivant Sciences' Total Liabilities history runs 6 years deep, the most recent figure standing at $416.3 million for Q1 2026.

• Quarterly Total Liabilities rose 66.68% year-over-year to $416.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $416.3 million (up 66.68% YoY) and the FY2026 annual result came in at $416.3 million, up 66.68% from the prior year.
• Total Liabilities was $416.3 million for Q1 2026 at Roivant Sciences, up from $251.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $822.5 million in Q2 2022 and bottomed at $216.7 million in Q2 2025.
• A 5-year average of $560.3 million and a median of $626.0 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 73.21% — and 2025, when it tumbled 67.73%.
• Roivant Sciences' Total Liabilities stood at $775.8 million in 2022, then dropped by 6.15% to $728.1 million in 2023, then tumbled by 64.79% to $256.4 million in 2024, then retreated by 2.04% to $251.1 million in 2025, then soared by 65.75% to $416.3 million in 2026.
• Business Quant data shows ROIV's Total Liabilities at $416.3 million in Q1 2026, $251.1 million in Q4 2025, and $257.1 million in Q3 2025.